Código QR (código de barras bidimensional)

Intermediate doses cytarabine after induction with CPX-351 for patients with secondary AML: safety and efficacy

Abstract Acute myeloid leukemia (AML), especially therapy-related (t-AML) or secondary AML (s-AML), presents complex therapeutic challenges. CPX-351, a liposomal formulation of cytarabine and daunorubicin, has demonstrated superior outcomes compared to standard 7 + 3 chemotherapy. However, optimal p...

Fuld beskrivelse

Na minha lista:
Principais autores: Salvatore Perrone, Andrea Corbingi, Calogero Vetro, Fanny Erika Palumbo, Paola Minetto, Carola Riva, Laura Cicconi, Chiara Vernarecci, Roberto Massimo Lemoli, Alessandro Pulsoni, Fabio Guolo
Format: Artigo
Sprog:Inglês
Udgivet: Springer 2026-02-01
Serier:Annals of Hematology
Fag:
Acute myeloid leukemia
CPX-351
Consolidation
ARA-C
Real-world evidence
Online adgang:https://doi.org/10.1007/s00277-026-06784-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker